http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0414386-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dbaced0995cda76fea038c684318a8fe |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-14 |
filingDate | 2004-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_959902a9b0cc04211b68b9382ce244ca http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fcc9dbcda9cfcd1823d9b6fdc810891e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c5db9012a19017528b78f36c2d6a0ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_783ea4cc932e2c962e96e33860f85480 |
publicationDate | 2006-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | BR-PI0414386-A |
titleOfInvention | compound, methods of manufacturing the same, for treating or preventing a disease, for activating er function in a bone cell, for inhibiting er function in a cell, for inhibiting il-6 expression, for inhibiting growth of an er-expressing neoplastic cell, for prevention of spermatogenesis, for prevention of an adverse reproductive effect associated with exposure to a lack of natural or chemically environmental hormonal balance, and, composition |
abstract | "COMPOSITE, METHODS FOR MANUFACTURING THE SAME, FOR TREATMENT OR PREVENTION OF A DISEASE, FOR ACTIVATION OF ER FUNCTION IN A BONE CELL, FOR INHIBITION OF ER FUNCTION IN A CELL, FOR INHIBITION OF THE EXPRESSION FOR ILL-INITION, 6 GROWTH OF A NEOPLASIC CELL EXPRESSING ER, FOR PREVENTION OF SPERMATOGENESIS, FOR PREVENTION OF AN ADVERSE REPRODUCTIVE EFFECT ASSOCIATED WITH EXPOSURE TO A LACK OF NATURAL OR CHEMICAL ENVIRONMENTAL, AND "COMPOSITION". Benzopyranone compounds having the following structure: wherein R 1, R 2, X, Y and n are as defined herein are described. Benzopyranone compounds are usable for the treatment or prevention of a bone resorption disease, a neoplastic disease, arthritis, an estrogen-exacerbated disease, or an estrogen-enhanced disease, comprising administering an effective amount of a compound. benzopyranone to a patient in need of treatment or prevention; activation of estrogen receptor ('ER') function in a bone cell; inhibition of ER function in a cancer cell; inhibition of interleukin-6 ('IL-6') expression in a cell; and inhibiting the growth of a neoplastic cell, comprising contacting the cell with an effective amount of a benzopyranone compound. |
priorityDate | 2003-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 73.